Apellis Pharmaceuticals, Inc.

Analyst - Citigroup
All forecasts
Forecast date: 30.08.2023
Expiration date: 29.08.2024
Start price: 42.21 $
Price target: 54 $
Closing price: 38.72 $
Current price: 27.44 $
Closing price 38.72 $ didn't reach the target 54 $ (-28.3%)

Detailed forecast is available by subscription


Subscribe

Other price forecasts for Apellis Pharmaceuticals, Inc.

Price target: 80 $
Potential: +191.55%
More details